DBNL anticorps (Middle Region)
Aperçu rapide pour DBNL anticorps (Middle Region) (ABIN631047)
Antigène
Voir toutes DBNL AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Specificité
- DBNL antibody was raised against the middle region of DBNL
-
Purification
- Affinity purified
-
Immunogène
- DBNL antibody was raised using the middle region of DBNL corresponding to a region with amino acids QESAVHPREIFKQKERAMSTTSISSPQPGKLRSPFLQKQLTQPETHFGRE
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
DBNL Blocking Peptide, (ABIN5613128), is also available for use as a blocking control in assays to test for specificity of this DBNL antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of DBNL antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- DBNL (Drebrin-Like (DBNL))
-
Autre désignation
- DBNL
-
Sujet
- DBNL is an actin-binding adapter protein. DBNL may act as a common effector of antigen receptor-signaling pathways in leukocytes. Its association with dynamin suggests that it may also connect the actin cytoskeleton to endocytic function.
-
Poids moléculaire
- 48 kDa (MW of target protein)
-
Pathways
- TCR Signaling, Regulation of Actin Filament Polymerization
Antigène
-